The
cardiac implantable electronic device market comprises implantable cardiac
pacemakers, implantable cardioverter defibrillators, and cardiac
resynchronization therapy devices. These devices help regulate heart rhythms
and treat fast, slow, or irregular heartbeats. Pacemakers help maintain a
regular heartbeat by delivering electrical signals to the heart. Implantable
cardioverter defibrillators monitor and control abnormal heart rhythms by
sending electrical signals to correct the abnormal rhythm. Cardiac
resynchronization therapy (CRT) devices coordinate the contractions of the left
and right ventricles. The growing prevalence of cardiovascular diseases and a
rapidly aging population are major factors fueling the demand for cardiac
implantable electronic devices.
The
Global cardiac implantable electronic device market is estimated to be valued
at US$ 32.38 Mn in 2024 and is expected to exhibit a CAGR of 2.2% over the
forecast period 2024 to 2030.
Key Takeaways
Key players operating in the cardiac implantable electronic device market are
Boston Scientific Corporation, GlaxoSmithKline plc., Johnson & Johnson,
Viatris, Sanofi S.A, and Medtronic Plc. These players manufacture a wide range
of devices, have a strong geographic presence, and invest heavily in R&D to
develop innovative products.
Key opportunities in the market include development of MRI-compatible devices,
minimally invasive device delivery systems, and remote monitoring devices.
MRI-compatible devices can help reduce risks associated with MRI scans for
pacemaker patients. Minimally invasive delivery systems can reduce implantation
time and risks. Remote monitoring devices enable continuous monitoring of
device functions and early detection of issues.
The market is witnessing rapid expansion in developing regions such as Asia
Pacific and Latin America due to growing healthcare investments, increasing
affordability, and rising cardiac disease prevalence in these regions. Major
players are actively collaborating with regional healthcare providers and
establishing manufacturing facilities in these regions to leverage
opportunities.
Market Drivers
The growing geriatric population susceptible to cardiac conditions is a major
market driver. According to the WHO, the global population aged 60 years and
older is projected to grow from 900 million in 2015 to 2 billion in 2050.
Additionally, the growing prevalence of risk factors like obesity, smoking, and
diabetes is contributing to increasing cardiovascular disease cases globally.
This is directly fueling demand for cardiac implantable devices.
PEST Analysis
Economic: Growing healthcare expenditures in major economies supporting market
growth. Rise in disposable incomes in developing nations increasing
affordability of such devices.
Social: Increasing incidence of cardiovascular diseases worldwide due to
changing lifestyles and growing geriatric population. Growing awareness among
patients regarding advantages of these devices.
Technological: Continuous innovations facilitating miniaturization of devices.
Emergence of bioresorbable electronics enabling dissolution of devices after
treatment completion. Development of devices capable of continuous monitoring
of cardiac health through remote patient monitoring.
The market is concentrated in developed regions of North America and Europe in
terms of value. North America currently accounts for the largest share due to
presence of advanced healthcare infrastructure and rising prevalence of
cardiovascular diseases. Europe is the second largest regional market owing to
growing elderly population and government support for adoption of therapeutic
devices.
The Asia Pacific region is poised to witness the fastest growth over the forecast
period with double digit CAGR. Factors such as improving healthcare
infrastructure, growing medical tourism industry and rising disposable incomes
in developing countries are driving higher adoption of cardiac implantable
electronic devices in the region. Additionally, increasing awareness regarding
availability of advanced treatment options for cardiovascular diseases is
supporting market expansion.
Get
more insights on- Cardiac
Implantable Electronic Device Market
Comments
Post a Comment